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A 57-year-old male presented with a 6-month history of blisters and painful erosions on the right buccal mucosa. No skin or other
mucosal involvement was seen. The findings of histopathological and direct immunofluorescence examinations were sufficient for
the diagnosis of oral mucous membrane pemphigoid in the context of adequate clinical correlation. No response was seen after
topical therapies and oral corticosteroids or dapsone. Intravenous immunoglobulin was started and repeated every three weeks.
Complete remission was achieved after three cycles and no recurrence was seen after two years of follow-up. The authors report a
rare unilateral presentation of oral mucous membrane pemphigoid on the right buccal and hard palate mucosa, without additional
involvement during a period of five years. Local trauma or autoimmune factors are possible etiologic factors for this rare disorder,
here with unique presentation.
1. Introduction
Mucous membrane pemphigoid (MMP) describes a hetero-
geneous group of chronic autoimmune subepithelial blister-
ing diseases, primarily affecting mucous membranes, with or
without skin involvement [1]. Although scarring is the clinical
hallmark, it may not be obvious in the oral mucosa, which is
the most commonly affected site. Lesions typically consist of
desquamative gingivitis, erythematous patches, blisters, and
erosions covered by pseudomembranes [2]. Autoantibodies
binding to the epithelial basement membrane zone (BMZ)
have been demonstrated in this subset, targeting bullous
antigens 1 and 2, laminin 332 and laminin 311, type VII
collagen, 𝛽4-integrin subunit, and some nonidentified basal
membrane zone antigens [3, 4]. Any oral cavity location can
be involved and patients usually have a good prognosis.
2. Case Presentation
A 57-year-old male presented with a 6-month history of
blisters and painful erosions on the right buccal mucosa. His
medical history was relevant for hypertension and hypothy-
roidism. He had been taking valsartan and levothyroxine for
years and denied the use of topical drugs and previous dental
procedures. On physical examination, the patient was found
to have few bullae, erosions, and pseudomembrane-covered
erosions on the right buccal mucosa (Figure 1).
No skin or other mucosal involvement was seen. He had
fragmented teeth with sharp edges adjacent to the lesions.
Laboratory evaluation was unremarkable. Histopathological
examination of bullous lesion revealed a subepithelial blister
with a mostly lymphocytic infiltrate in the upper corion
(Figure 2).
Direct immunofluorescence of peribullous mucosa
showed a linear band of IgG, IgA, and complement compo-
nent 3 (C3) at the epithelial BMZ (Figure 3).
ELISA was negative for antibodies against bullous pem-
phigoid antigens 180 and 230 and desmogleins 1 and 3.
Correlation between these features allowed the diagnosis of
MMP. Application of dipropionate betamethasone cream,
twice daily, was started. After one year the patient had
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Figure 1: At presentation multiple painful erosions and
pseudomembrane-covered erosions on the right buccal mucosa
were seen.
Figure 2: Histopathological examination of a bullous lesion
revealed a subepithelial blister with a mostly lymphocytic and
neutrophilic dense inflammatory infiltrate in the upper corion
(hematoxylin and eosin, original magnification ×100).
persistent bullae and erosions on the right buccalmucosa that
healedwithout scarring.Oral prednisolone (0.5mg/kg/d)was
started for six months, and as no response was achieved,
treatment with dapsone (100mg/d) was administered during
one year. Further involvement of the right hard palatemucosa
occurred, erosions were extremely painful, and the patient
had difficulty in eating and depression (Figure 4).
Intravenous immunoglobulin (IVIg) at a dose of
2 g/kg/cycle was started and repeated every three weeks.
Complete remission was achieved after three cycles. IVIg
therapy was maintained for six additional months. No
recurrence was seen after three years of follow-up (Figure 5).
3. Discussion
The findings of direct immunofluorescence were sufficient
for the diagnosis of MMP in the context of adequate clinical
correlation [1]. Patients with MMP with oral involvement
often exhibit bilateral lesions. We reported a unilateral
presentation on the right buccal and hard palate mucosa,
without additional involvement during a period of five
Figure 3: Direct immunofluorescence showed a linear band of IgG,
IgA, and C3 at the epithelial BMZ (original magnification ×40).
Figure 4: No response after topical and systemic treatment with
corticosteroids and dapsone, with further involvement of the right
hard palate mucosa.
Figure 5: Complete response after IVIg therapy and only a delicate
white pattern of reticulated scarring on the buccal mucosa had been
seen after 3 years of follow-up.
years. A possible previous chronic inflammatory process of
the mucosa associated with local trauma probably exposed
hidden antigens of the BMZ and evoked a secondary autoim-
mune response, explaining this mosaic of disease [2]. Direct
immunofluorescence findings and the complete response
after IVIg also suggest an autoimmune etiology, here with
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unique presentation [3, 5]. Since management of MMP is
often difficult, our case also shows a complete response to a
therapeutic option not commonly used in the limited or less
severe disease.
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